GSK press releases Follow GSK provides update on belrestotug development programme GSK with its development partner iTeos Therapeutics, Inc., has confirmed it is ending the development programme for belrestotug. https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-belrestotug-development-programme/ gsk.com
